Inflammation-associated alterations to the intestinal microbiota reduce colonization resistance against non-typhoidal Salmonella during concurrent malaria parasite infection

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mooney, Jason P ^a   Lokken, Kristen L ^a   Byndloss, Mariana X ^a   George, Michael D ^a   Velazquez, Eric M ^a   Faber, Franziska ^a   Butler, Brian P ^a,b   Walker, Gregory T ^a   Ali, Mohamed M ^c,d   Potts, Rashaun ^a   Tiffany, Caitlin ^a   Ahmer, Brian M M ^c   Luckhart, Shirley ^a   Tsolis, Renée M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST GEORGE S UNIVERSITY   (Grenada)

^c OHIO STATE UNIVERSITY   (United States)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; C57BL MOUSE; CECUM; DISEASE PREDISPOSITION; FEMALE; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; MALARIA; MICROBIOLOGY; MIXED INFECTION; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM YOELII; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS;

ANIMALS; CECUM; COINFECTION; DISEASE SUSCEPTIBILITY; FEMALE; GASTROINTESTINAL MICROBIOME; INTESTINAL MUCOSA; MALARIA; MICE, INBRED C57BL; PLASMODIUM YOELII; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84942916890     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14603     Document Type: Article

References (46)

1. Gordon, M. A. Salmonella infections in immunocompromised adults. J. Infect. 56, 413-422, doi: S0163-4453(08)00133-3 (2008).
2. Bronzan, R. N. et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J. Infect. Dis. 195, 895-904, doi: JID37287m (2007).
3. Walsh, A. L., Phiri, A. J., Graham, S. M., Molyneux, E. M. & Molyneux, M. E. Bacteremia in febrile Malawian children: clinical and microbiologic features. Pediatr. Infect. Dis. J. 19, 312-318 (2000).
4. Kingsley, R. A. et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 19, 2279-2287, doi: gr.091017.109 (2009).
5. Gordon, M. A. et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis. 46, 963-969, doi: 10.1086/529146 (2008).
6. Oundo, J. O. et al. Non-typhi salmonella in children with severe malaria. East Afr. Med. J. 79, 633-639 (2002).
7. Kariuki, S. et al. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol. 6, 101, doi: 1471-2180-6-101 (2006).
8. Takem, E. N., Roca, A. & Cunnington, A. The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review. Malar. J. 13, 400, doi: 10.1186/1475-2875-13-400 (2014).
9. Reddy, E. A., Shaw, A. V. & Crump, J. A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 417-432, doi: S1473-3099(10)70072-4 (2010).
10. Cunnington, A. J., de Souza, J. B., Walther, M. & Riley, E. M. Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat. Med. 18, 120-127, doi: 10.1038/nm.2601 (2012).
11. Lokken, K. L. et al. Malaria parasite infection compromises control of concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated alteration of myeloid cell function. PLoS Pathog. 10, e1004049, doi: 10.1371/journal.ppat.1004049 (2014).
12. Mooney, J. P. et al. The mucosal inflammatory response to non-typhoidal Salmonella in the intestine is blunted by IL-10 during concurrent malaria parasite infection. Mucosal Immunol. 7, 1302-1311, doi: 10.1038/mi.2014.18 (2014).
13. Roux, C. M. et al. Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to Nontyphoidal Salmonella enterica serovar typhimurium infection in mice. Infect. Immun. 78, 1520-1527, doi: IAI.00887-09 (2010).
14. Chau, J. Y. et al. Malaria-associated L-arginine deficiency induces mast cell-associated disruption to intestinal barrier defenses against nontyphoidal Salmonella bacteremia. Infect. Immun. 81, 3515-3526, doi: 10.1128/IAI.00380-13 (2013).
15. Wilairatana, P., Meddings, J. B., Ho, M., Vannaphan, S. & Looareesuwan, S. Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria. Clin. Infect. Dis. 24, 430-435 (1997).
16. Molyneux, M. E. et al. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am. J. Trop. Med. Hyg. 40, 470-476 (1989).
17. Haldar, K., Murphy, S. C., Milner, D. A. & Taylor, T. E. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu. Rev. Pathol. 2, 217-249, doi: 10.1146/annurev.pathol.2.010506.091913 (2007).
18. Milner, D. A., Jr. et al. Quantitative Assessment of Multiorgan Tissue Sequestration in Fatal Pediatric Cerebral Malaria. J. Infect. Dis. doi: 10.1093/infdis/jiv205 (2015).
19. Seydel, K. B., Milner, D. A., Jr., Kamiza, S. B., Molyneux, M. E. & Taylor, T. E. The distribution and intensity of parasite sequestration in comatose Malawian children. J. Infect. Dis. 194, 208-205, doi: 10.1086/505078 (2006).
20. Mizobuchi, H. et al. The accumulation of macrophages expressing myeloid-related protein 8 (MRP8) and MRP14 in the spleen of BALB/cA mice during infection with Plasmodium berghei. Exp. Parasitol. 138, 1-8, doi: 10.1016/j.exppara.2014.01.003 (2014).
21. Freitas do Rosario, A. P. et al. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188, 1178-1190, doi: 10.4049/jimmunol.1102755 (2012).
22. Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493-497 (1938).
23. Raffatellu, M. et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5, 476-486, doi: S1931-3128(09)00108-5 (2009).
24. Stecher, B. et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5, 2177-2189, doi: 10.1371/journal.pbio.0050244 (2007).
25. Winter, S. E. & Baumler, A. J. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5, 71-73, doi: 10.4161/gmic.27129 (2014).
26. Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711, doi: 10.1126/science.1232467 (2013).
27. Hapfelmeier, S. et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J. Immunol. 174, 1675-1685, doi: 174/3/1675 [pii] (2005).
28. Tsolis, R. M., Adams, L. G., Ficht, T. A. & Baumler, A. J. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect. Immun. 67, 4879-4885 (1999).
29. Levine, M. M. et al. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1, 1119-1122 (1978).
30. Luckey, T. D. Introduction to intestinal microecology. Am. J. Clin. Nutr. 25, 1292-1294 (1972).
31. Tsolis, R. M., Xavier, M. N., Santos, R. L. & Baumler, A. J. How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect. Immun. 79, 1806-1814, doi: IAI.01369-10 (2011).
32. Reeves, A. E. et al. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2, 145-158 (2011).
33. Garner, C. D. et al. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect. Immun. 77, 2691-2702, doi: 10.1128/IAI.01570-08 (2009).
34. Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104, 13780-13785, doi: 10.1073/pnas.0706625104 (2007).
35. Giaffer, M. H., Holdsworth, C. D. & Duerden, B. I. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J. Med. Microbiol. 35, 238-243 (1991).
36. Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F. & Veldhuyzen van Zanten, S. J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136-4141, doi: 10.1128/JCM.01004-06 (2006).
37. Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129, doi: 10.1016/j.chom.2007.06.010 (2007).
38. Seksik, P. et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237-242 (2003).
39. Stojiljkovic, I., Baumler, A. J. & Heffron, F. Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. J. Bacteriol. 177, 1357-1366 (1995).
40. Prentki, P. & Krisch, H. M. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29, 303-313 (1984).
41. Rivera-Chavez, F. et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 9, e1003267, doi: 10.1371/journal.ppat.1003267 (2013).
42. Roux, C. M. et al. Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice. Cell. Microbiol. 9, 1851-1869, doi: 10.1111/j.1462-5822.2007.00922.x (2007).
43. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336, doi: 10.1038/nmeth.f.303 (2010).
44. Arndt, D. et al. METAGENassist: a comprehensive web server for comparative metagenomics. Nucleic Acids Res. 40, W88-95, doi: 10.1093/nar/gks497 (2012).
45. Huson, D. H., Auch, A. F., Qi, J. & Schuster, S. C. MEGAN analysis of metagenomic data. Genome Res. 17, 377-386, doi: 10.1101/gr.5969107 (2007).
46. Robertson, C. E. et al. Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data. Bioinformatics 29, 3100-3101, doi: 10.1093/bioinformatics/btt526 (2013).